Cell Death Discovery,
Journal Year:
2024,
Volume and Issue:
10(1)
Published: June 28, 2024
Abstract
This
study
assesses
the
neuroprotective
potential
of
CPP-P1,
a
conjugate
an
anti-apoptotic
peptain-1
(P1)
and
cell-penetrating
peptide
(CPP)
in
vitro,
vivo,
ex
vivo
glaucoma
models.
Primary
retinal
ganglion
cells
(RGCs)
were
subjected
to
either
neurotrophic
factor
(NF)
deprivation
for
48
h
or
endothelin-3
(ET-3)
treatment
24
received
CPP-P1
vehicle.
RGC
survival
was
analyzed
using
Live/Dead
assay.
Axotomized
human
explants
treated
with
vehicle
seven
days,
stained
marker
RBPMS,
analyzed.
Brown
Norway
(BN)
rats
elevated
intraocular
pressure
(IOP)
weekly
intravitreal
injections
six
weeks.
function
evaluated
pattern
electroretinogram
(PERG).
axonal
damage
also
assessed.
RGCs
from
ocular
hypertensive
days
isolated
transcriptomic
analysis.
NF
used
qPCR
target
confirmation.
led
significant
loss
RGCs,
which
markedly
reduced
by
treatment.
decreased
ET-3-mediated
death.
In
explants,
loss.
IOP
elevation
resulted
mid-peripheral
peripheral
retinas
compared
that
naive
rats,
significantly
PERG
amplitude
decline
IOP-elevated
mitigated
Following
BN
analysis
showed
over
6,000
differentially
expressed
genes
group
vehicle-treated
group.
Upregulated
pathways
included
CREB
signaling
synaptogenesis.
A
increase
Creb1
mRNA
phosphorylated
Creb
observed
CPP-P1-treated
RGCs.
Our
is
through
enhancement
several
settings
mimic
glaucomatous
conditions.
The
findings
this
are
as
they
address
pressing
need
development
efficacious
therapeutic
strategies
maintain
viability
functionality
associated
glaucoma.
Mitochondrial
defects
are
tightly
linked
to
axon
degeneration,
yet
the
underlying
cellular
mechanisms
remain
poorly
understood.
In
Caenorhabditis
elegans,
PVQ
axons
that
lack
mitochondria
degenerate
spontaneously
with
age.
Using
an
unbiased
genetic
screen,
we
found
cell-specific
activation
of
CaMKII/UNC-43
suppresses
degeneration
due
loss
mitochondria.
Unexpectedly,
activates
conserved
Sarm1/TIR-1-ASK1/NSY-1-p38
MAPK
pathway
and
eventually
transcription
factor
CEBP-1
protect
against
degeneration.
addition,
show
disrupting
a
trafficking
complex
composed
calsyntenin/CASY-1,
Mint/LIN-10,
kinesin
Further
analysis
indicates
disruption
this
CaMKII-Sarm1-MAPK
through
L-type
voltage-gated
calcium
channels.
Our
findings
identify
CaMKII
as
pivot
point
between
mitochondrial
describe
how
it
is
regulated,
uncover
surprising
neuroprotective
role
for
Sarm1-p38
in
context.
Advanced Science,
Journal Year:
2022,
Volume and Issue:
9(22)
Published: May 26, 2022
Neural
stem
cell
(NSC)-based
therapy
holds
great
promise
for
the
treatment
of
neurodegenerative
diseases.
Presently,
however,
it
is
hindered
by
poor
functional
neuronal
differentiation.
Electrical
stimulation
considered
one
most
effective
ways
to
promote
differentiation
NSCs.
In
addition
surgically
implanted
electrodes,
traditional
electrical
includes
wires
connected
external
power
supply,
and
an
additional
surgery
required
remove
electrodes
or
following
stimulation,
which
may
cause
secondary
injuries
infections.
Herein,
a
novel
method
reported
generation
wireless
signals
on
Au
nanostrip
array
leveraging
effect
electromagnetic
induction
under
rotating
magnetic
field.
The
intensity
generated
depends
rotation
speed
field
strength.
array-mediated
electric
promotes
NSC
into
mature
neurons
within
5
days,
at
mRNA,
protein,
function
levels.
rate
faster
least
days
than
that
in
cells
without
treatment.
array-based
device
also
accelerates
NSCs
vivo.
accelerate
has
advantages
wireless,
timely,
localized
precise
controllability,
noninvasive
supplementation.
Neural Regeneration Research,
Journal Year:
2024,
Volume and Issue:
20(2), P. 587 - 597
Published: Jan. 31, 2024
JOURNAL/nrgr/04.03/01300535-202502000-00034/figure1/v/2024-05-28T214302Z/r/image-tiff
Several
studies
have
found
that
transplantation
of
neural
progenitor
cells
(NPCs)
promotes
the
survival
injured
neurons.
However,
a
poor
integration
rate
and
high
risk
tumorigenicity
after
cell
limits
their
clinical
application.
Small
extracellular
vesicles
(sEVs)
contain
bioactive
molecules
for
neuronal
protection
regeneration.
Previous
shown
stem/progenitor
cell-derived
sEVs
can
promote
recovery
neurological
function
in
neurodegenerative
eye
diseases
other
diseases.
In
this
study,
we
intravitreally
transplanted
derived
from
human
induced
pluripotent
stem
(hiPSCs)
hiPSCs-differentiated
NPCs
(hiPSC-NPC)
mouse
model
optic
nerve
crush.
Our
results
show
these
injected
were
ingested
by
retinal
cells,
especially
those
localized
ganglion
layer.
Treatment
with
hiPSC-NPC-derived
mitigated
crush-induced
degeneration,
regulated
microenvironment
inhibiting
excessive
activation
microglia.
Component
analysis
further
revealed
hiPSC-NPC
transported
neuroprotective
anti-inflammatory
miRNA
cargos
to
target
which
had
protective
effects
on
RGCs
injury.
These
findings
suggest
are
promising
cell-free
therapeutic
strategy
neuropathy.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: March 11, 2024
Previous
studies
of
neuronal
survival
have
primarily
focused
on
identifying
intrinsic
mechanisms
controlling
the
process.
This
study
explored
how
intercellular
communication
contributes
to
retinal
ganglion
cell
(RGC)
following
optic
nerve
crush
based
single-cell
RNA-seq
analysis.
We
observed
transcriptomic
changes
in
cells
response
injury,
with
astrocytes
and
Müller
glia
having
most
interactions
RGCs.
By
comparing
RGC
subclasses
characterized
by
distinct
resilience
death,
we
found
that
high-survival
RGCs
tend
more
ligand-receptor
neighboring
cells.
identified
47
stronger
RGCs,
likely
mediating
neuroprotective
effects.
validated
one
target,
μ-opioid
receptor
(Oprm1),
be
three
injury
models.
Although
endogenous
Oprm1
is
preferentially
expressed
intrinsically
photosensitive
its
effect
can
transferred
other
pan-RGC
overexpression
Oprm1.
Lastly,
manipulating
activity
improved
visual
functions
mice.
eNeuro,
Journal Year:
2024,
Volume and Issue:
11(3), P. ENEURO.0478 - 23.2024
Published: March 1, 2024
Neuroprotection
after
injury
or
in
neurodegenerative
disease
remains
a
major
goal
for
basic
and
translational
neuroscience.
Retinal
ganglion
cells
(RGCs),
the
projection
neurons
of
eye,
degenerate
optic
neuropathies
axon
injury,
there
are
no
clinical
therapies
to
prevent
their
loss
restore
connectivity
targets
brain.
Here
we
demonstrate
profound
neuroprotective
effect
exogenous
expression
various
Ca
2+
/calmodulin-dependent
protein
kinase
II
(CaMKII)
isoforms
mice.
A
dramatic
increase
RGC
survival
following
nerve
trauma
was
elicited
by
constitutively
active
variants
multiple
CaMKII
RGCs
using
adeno-associated
viral
(AAV)
vectors
across
100-fold
range
AAV
dosing
vivo.
Despite
this
neuroprotection,
however,
short-distance
sprouting
suppressed
CaMKII,
long-distance
regeneration
several
pro-axon
growth
treatments
likewise
inhibited
even
as
further
enhanced
survival.
Notably,
dose-escalation
study,
AAV-expressed
more
potent
suppression
than
promotion
That
diffuse
overexpression
strongly
promotes
may
be
clinically
valuable
neuroprotection
per
se.
However,
associated
strong
demonstrates
need
understanding
intracellular
domain-
target-specific
activities
development
signaling
pathway-directed
strategies
treatment
neuropathies.
Frontiers in Endocrinology,
Journal Year:
2022,
Volume and Issue:
13
Published: Oct. 12, 2022
Glaucoma
is
the
leading
cause
of
irreversible
blindness.
The
progressive
degeneration
retinal
ganglion
cells
(RGCs)
major
characteristic
glaucoma.
Even
though
control
intraocular
pressure
could
delay
loss
RGCs,
current
clinical
treatments
cannot
protect
them
directly.
overactivation
N-methyl-D-aspartic
acid
(NMDA)
receptors
by
excess
glutamate
(Glu)
among
important
mechanisms
RGC
death
in
glaucoma
progression.
Melatonin
(MT)
an
indole
neuroendocrine
hormone
mainly
secreted
pineal
gland.
This
study
aimed
to
investigate
therapeutic
effect
MT
on
excitotoxicity
mouse
RGCs
and
R28
cells.
Glu-induced
cell
model
NMDA-induced
injury
were
established.
was
applied
vitreous
cavity
mice
intravitreal
injection.
Cell
counting
kit-8
assay
propidium
iodide/Hoechst
performed
evaluate
viability.
Reactive
oxygen
species
glutathione
synthesis
assays
used
detect
oxidative
stress
state
Retina
immunofluorescence
hematoxylin
eosin
staining
assess
counts
structure.
Flash
visual-evoked
potential
visual
function
mice.
RNA
sequencing
retina
explore
underlying
protection.
Our
results
found
that
treatment
successfully
from
Glu
decrease
reactive
species.
Also,
rescued
protected
enriches
indications
glaucoma,
providing
practical
research
ideas
for
its
comprehensive
prevention
treatment.
Journal of Personalized Medicine,
Journal Year:
2022,
Volume and Issue:
12(11), P. 1884 - 1884
Published: Nov. 10, 2022
Glaucoma
is
a
neurodegenerative
disease
that
affects
primarily
the
retinal
ganglion
cells
(RGCs).
Increased
intraocular
pressure
(IOP)
one
of
major
risk
factors
for
glaucoma.
The
mainstay
current
glaucoma
therapy
limited
to
lowering
IOP;
however,
controlling
IOP
in
certain
patients
can
be
futile
slowing
progression.
understanding
potential
biomolecular
processes
occur
glaucomatous
degeneration
allows
development
treatments
modulate
death
RGCs.
Neuroprotection
modification
RGCs
and
microenvironment
neurons
promote
neuron
survival
function.
Numerous
studies
have
revealed
effective
neuroprotection
modalities
animal
models
glaucoma;
nevertheless,
clinical
translation
remains
challenge.
In
this
review,
we
select
most
clinically
relevant
treatment
strategies,
summarize
preclinical
data
as
well
recent
therapeutic
advances
IOP-independent
research,
discuss
feasibility
hurdles
each
approach
based
on
possible
pathogenic
mechanisms.
We
also
mechanisms
various
agents
related
glutamate
excitotoxicity.
Investigative Ophthalmology & Visual Science,
Journal Year:
2023,
Volume and Issue:
64(4), P. 31 - 31
Published: April 26, 2023
Purpose:
Strategies
for
neuroprotection
are
the
main
targets
of
glaucoma
research.
The
neuroprotective
properties
SRT2104
administration
have
been
proven
in
central
nervous
system
degeneration
diseases
through
activation
nicotinamide
adenine
dinucleotide-dependent
deacetylase-silence
information
regulator
1
(Sirt1).
Here,
we
investigated
whether
could
protect
retina
from
ischemia/reperfusion
(I/R)
injury
and
underlying
mechanisms.
Methods:
was
intravitreally
injected
immediately
after
I/R
induction.
RNA
protein
expression
were
detected
by
quantitative
real-time
PCR
Western
blot.
Protein
distribution
examined
immunofluorescence
staining.
Retinal
structure
function
analyzed
hematoxylin
eosin
staining,
optical
coherence
tomography,
electroretinogram.
Optic
nerve
axons
quantified
using
toluidine
blue
Cellular
apoptosis
senescence
evaluated
TUNEL
assay
SA-β-gal
Results:
Sirt1
decreased
dramatically
effectively
enhanced
stability
without
significantly
influencing
mRNA
synthesis.
alone
exerted
no
influence
on
normal
retinas.
However,
intervention
protected
inner
retinal
neurons;
partially
restored
injury.
I/R-induced
cellular
alleviated
administration.
Additionally,
markedly
reduced
neuroinflammation,
including
reactive
gliosis,
vascular
inflammation,
overexpression
pro-inflammatory
cytokines
Mechanistically,
acetylation
p53,
NF-κB
p65,
STAT3
reversed
intervention.
Conclusions:
We
demonstrated
that
potent
protective
effects
against
enhancing
Sirt1-mediated
deacetylation
suppressing
apoptosis,
senescence,
neuroinflammation-related
pathways.
Journal of Controlled Release,
Journal Year:
2023,
Volume and Issue:
363, P. 641 - 656
Published: Oct. 13, 2023
Optic
neuropathy
is
the
leading
cause
of
irreversible
blindness
and
characterized
by
progressive
degeneration
retinal
ganglion
cells
(RGCs).
Several
studies
have
demonstrated
that
transplantation
Schwann
(SCs)
a
promising
candidate
therapy
for
optic
intravitreally
transplanted
exert
their
effect
via
paracrine
actions.
Extracellular
vesicle
(EV)-based
therapies
are
increasingly
recognized
as
potential
strategy
cell
replacement
therapy.
In
this
study,
we
aimed
to
investigate
neuroprotective
regenerative
effects
SC-EVs
following
nerve
injury.
We
found
were
internalized
RGCs
in
vitro
vivo
without
any
transfection
reagents.
Intriguingly,
significantly
enhanced
survival
axonal
growth
primary
coculture
system.
rat
crush
model,
mitigated
RGC
degeneration,
prevented
loss,
preserved
thickness
complex,
statistically
significant
improvement
counts
measurements.
Mechanistically,
activated
cAMP-response
element
binding
protein
(CREB)
signaling
pathway
regulated
reactive
gliosis
ONC
rats,
which
crucial
protection
regeneration.
These
findings
provide
novel
insights
into
properties
SC-EVs,
suggesting
cell-free
therapeutic
natural
biomaterials
neurodegenerative
diseases
central
nervous